VEGFA and telomere syndrome: Currently, several drugs targeting vascular endothelial growth factor (VEGF) for STS have entered the clinical trial stage and some of them have shown good clinical effects (Kuenen et al., 2003; Suttle et al., 2004; D’Adamo et al., 2005; Dalal et al., 2005).